Elevated Oct4 levels are regarded as one of the most important indicators of cancer cell chemotherapy resistance; however, increasing miR-145 levels can reduce expression of Oct4 and its target gene Zeb1, counteracting the increase in Oct4 levels generated by pemetrexed treatment, a type of chemotherapy [48]. This evidence concerns the gene POU5F1 and cancer.